Lilly is going after sellers of its experimental obesity drug, which has not been approved for human use but is already being sold online.
Recap by typeshit. Post by Facebook on Facebook.
A man says Mounjaro and Trulicity caused his gastroparesis, and the clip walks through who must warn patients about side effects under Indiana law.
Alicia Butterfield claims Anthem denied her Zepbound once the drug got her below morbid obesity. A Los Angeles judge stayed her case pending arbitration.
STAT
Members of Congress from both parties want the FDA to stop imports of copycat versions of Eli Lilly's experimental obesity drug, which is still in trials.
The lawsuits center on sudden vision loss, a possible link researchers have been studying in weight loss drugs for several years.
Sinai Health says early research hints semaglutide-type drugs may ease inflammation apart from weight loss, and Ren is working out the mechanism.
The interim access policy, requested by the American Academy of Peptide Medicine, now sits with OMB. AAPM chair Lee Rosebush calls it a step toward regulated access.
Loading…